Business Standard

Thursday, December 19, 2024 | 10:30 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Abbott India reports 1.96% decline in Q4 net profit to Rs 110.97 crore

Revenue from operations stood at Rs 961.20 crorefor the quarter under consideration as against Rs 906.31 crore for the same period year ago

drug, medicine, pharmaceutical, pharma
Premium

Shares of Abbott India closed at Rs16,603.30per scrip on the BSE, down 2.81 per cent over previous close

Agencies
Drug firm Abbott India on Monday reported a 1.96 per cent decline in net profit to Rs 110.97 crore for the quarter ended on March 31, 2020, mainly on account of rise in expenses.

The company had posted a net profit of Rs 113.19 crore for the corresponding period of previous fiscal, Abbott India said in a BSE filing.

Revenue from operations stood at Rs 961.20 crore for the quarter under consideration as against Rs 906.31 crore for the same period year ago, news agency PTI reported.

Total expense for the quarter ended March 2020 was at Rs 840.40 crore.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in